Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11
- PMID: 27346191
- DOI: 10.1016/j.scr.2016.02.042
Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11
Abstract
Spinocerebellar ataxia type 3 (SCA3) is a dominantly inherited neurodegenerative disease caused by an expansion of the CAG-repeat in ATXN3. In this study, induced pluripotent stem cells (iPSCs) were generated from SCA3 patient dermal fibroblasts by electroporation with episomal plasmids encoding L-MYC, LIN28, SOX2, KLF4, OCT4 and short hairpin RNA targeting P53. The resulting iPSCs had normal karyotype, were free of integrated episomal plasmids, expressed pluripotency markers, could differentiate into the three germ layers in vitro and retained the disease-causing ATXN3 mutation. Potentially, this iPSC line could be a useful tool for the investigation of SCA3 disease mechanisms.
Copyright © 2016 Roslin Cells Ltd. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.Stem Cell Res. 2016 May;16(3):553-6. doi: 10.1016/j.scr.2016.02.040. Epub 2016 Mar 9. Stem Cell Res. 2016. PMID: 27346190
-
Generation of induced pluripotent stem cells from a patient with spinocerebellar ataxia type 3.Stem Cell Res. 2017 Jan;18:29-32. doi: 10.1016/j.scr.2016.12.017. Epub 2016 Dec 9. Stem Cell Res. 2017. PMID: 28395798
-
Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3.Stem Cell Res. 2016 Sep;17(2):306-317. doi: 10.1016/j.scr.2016.07.004. Epub 2016 Aug 16. Stem Cell Res. 2016. PMID: 27596958
-
Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.Stem Cell Res. 2018 Jul;30:171-174. doi: 10.1016/j.scr.2018.06.006. Epub 2018 Jun 11. Stem Cell Res. 2018. PMID: 29936336
-
Recent therapeutic prospects for Machado-Joseph disease.Curr Opin Neurol. 2020 Aug;33(4):519-526. doi: 10.1097/WCO.0000000000000832. Curr Opin Neurol. 2020. PMID: 32657894 Review.
Cited by
-
Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line.Stem Cell Res. 2019 Aug;39:101504. doi: 10.1016/j.scr.2019.101504. Epub 2019 Jul 16. Stem Cell Res. 2019. PMID: 31374463 Free PMC article.
-
Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.Stem Cell Rev Rep. 2022 Feb;18(2):441-456. doi: 10.1007/s12015-021-10184-0. Epub 2021 May 25. Stem Cell Rev Rep. 2022. PMID: 34031815 Free PMC article. Review.
-
Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications.Cell Transplant. 2019 Dec;28(1_suppl):112S-131S. doi: 10.1177/0963689719886534. Epub 2019 Nov 14. Cell Transplant. 2019. PMID: 31722555 Free PMC article. Review.
-
A comprehensive review of iPS cell line-based disease modelling of the polyglutamine spinocerebellar ataxias 2 and 3: a focus on the research outcomes.Ann Med Surg (Lond). 2024 Mar 19;86(6):3487-3498. doi: 10.1097/MS9.0000000000001984. eCollection 2024 Jun. Ann Med Surg (Lond). 2024. PMID: 38846892 Free PMC article. Review.
-
Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.Biomed Res Int. 2016;2016:6701793. doi: 10.1155/2016/6701793. Epub 2016 Oct 25. Biomed Res Int. 2016. PMID: 27847820 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous